Skip to main content

Enric Domingo Ribas

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Enric Domingo Ribas

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

RECAVA - Red Temática de Investigación en Enfermedades Cardiovasculares

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Antonia Sambola Ayala, Antonio Rodríguez Sinovas, Joan Castell Conesa, RECAVA - Red Temática de Investigación en Enfermedades Cardiovasculares, Elsa Nieto Santa, Teresa González Alujas, Lourdes Trobo Redondo, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Ignasi Barba Vert, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Mª Ángeles Carmona Ramírez
Funding agency: Instituto de Salud Carlos III
Funding: 1548057.34
Reference: RD06/0014/0025
Duration: 01/01/2007 - 31/12/2013

Patologia Cardiocirculatòria

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Antonia Sambola Ayala, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Patologia Cardiocirculatòria, Elsa Nieto Santa, Teresa González Alujas, Lourdes Trobo Redondo, Enric Domingo Ribas, Jaume Sagristà Sauleda, Aida Ribera Sole, Patologia Cardiocirculatòria, Rosa María Lidón Corbi, Ignasi Barba Vert, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50600
Reference: 2005SGR 00985
Duration: 01/01/2006 - 31/12/2009

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Andrea Freixa Benavente

Andrea Freixa Benavente

Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Gemma  Duarri Llado

Gemma Duarri Llado

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Jordi Masiá Gridilla

Jordi Masiá Gridilla

Predoctoral researcher
New Technologies and Craniofacial Microsurgery
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.